Our Mission
Understand the regulatory landscape. Discover career opportunities. Build confidence in practice.
Starting a career in clinical research, drug development or regulatory affairs requires scientific expertise as well as knowledge of regulatory processes, quality standards and collaboration between industry and authorities. These topics are often covered only briefly at university.
Our seminars provide practical foundational knowledge, helping you understand regulatory relationships and place common tasks and interfaces in context.
That is where vetklinfo comes in
We want to show you early on how scientific development, regulatory requirements and industry practice interact.
Our aim is to bridge the gap between university education and the needs of industry and regulatory authorities.
Current and future challenges
- Artificial intelligence (AI) and data-driven development: AI-based methods can support the analysis of scientific data, study planning and more objective data collection. Transparent results, suitable validation and reliable data are essential. Our seminars help you understand these methods and their regulatory interfaces.
- Innovative therapies: Monoclonal antibodies, gene and cell therapies, RNA-based approaches and phage therapies open up new development opportunities. Depending on the product and its stage of development, they raise specific questions about quality, safety, efficacy and manufacturing. For veterinary medicinal products, these approaches must be assessed within the applicable regulatory framework.
- Early regulatory strategy: The target indication, authorisation route and evidence requirements should be considered together from the start of development. Aligning non-clinical and clinical studies, manufacturing and quality standards, and engaging with authorities early can help identify development risks and improve planning.
- The availability of veterinary medicinal products remains a particular challenge in limited markets. Scientific innovation must therefore be effective and safe, while also being feasible within regulatory and economic constraints.
- Antimicrobial resistance, emerging disease risks and changing needs in animal health and prevention are increasing demand for new medicines, vaccines and therapeutic alternatives. At the same time, sustainability, animal welfare and reducing the use of antimicrobial substances are becoming increasingly important.
- Pharmacovigilance and lifecycle management are essential parts of a medicinal product's regulatory lifecycle. Requirements continue after authorisation and include ongoing assessment of safety, benefits and risks, as well as responding to new scientific and regulatory findings.
- Regulatory requirements continue to evolve. The European framework for veterinary medicinal products, in force since 2022, continues to be shaped by guidelines, scientific recommendations and practical experience. For work in clinical research, drug development, regulatory affairs, pharmacovigilance and quality assurance, up-to-date regulatory knowledge is therefore essential.
Understand the knowledge. See how the pieces fit together. Put it into practice.
vetklinfo connects scientific foundations with regulatory practice, offering career guidance for those starting out and in-depth continuing education for working professionals.